Merck & Co. Inc. diskutieren
Merck & Co. Inc.
WKN: A0YD8Q / Symbol: MRK / Name: Merck & Co / Aktie / Pharmazeutika / Large Cap /
85,90 €
2,13 %
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $122.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE: MRK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $115.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $125.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $92.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE:MRK) had its price target raised by analysts at Bank of America Corporation from $105.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $130.00 price target on the stock, up previously from $82.00.
Ratings data for MRK provided by MarketBeat
Neueste Beiträge
The_Goldman_Sachs_Gr in Accenture plc A diskutieren